Metraipolis › archive › dc_fc10c78d617e

Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41599182
DOI
10.3390/pharmaceutics18010075
License (as archived)
solo-consultazione
Archived
2026-11-07T00:03:20.285Z
SHA-256 of the archived text
94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a
Stable URL of this page
https://metraipolis.com/documento/dc_fc10c78d617e

How to cite

Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182 — Europe PMC (en), https://europepmc.org/article/MED/41599182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc10c78d617e (Metraipolis archive dc_fc10c78d617e, sha256 94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a)
BibTeX
@misc{dcfc10c78d617e,
  title = {Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine — Europe PMC PMID:41599182},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599182},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc10c78d617e; sha256 94cda1b72653c6ef140e9f7727b3cb2e3ced63ce44c1dd8910e16ed4bc55075a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599182. Agents can read the archived copy with the MCP tool read_document.